Patent · US Active

Targeted RNA editing

US10676737B2 · kind B2 · utility

10Cited by
0References
31Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 17, 2015
Grant dateJun 9, 2020
Priority date
Expiry dateApr 3, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2310/533
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

RNA editing is achieved using oligonucleotide constructs comprising (i) a targeting portion specific for a target nucleic acid sequence to be edited and (ii) a recruiting portion capable of binding and recruiting a nucleic acid editing entity naturally present in the cell. The nucleic acid editing entity, such as ADAR, is redirected to a preselected target site by means of the targeting portion, thereby promoting editing of preselected nucleotide residues in a region of the target RNA which corresponds to the targeting portion.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.